Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - ciprofloxacinum - compresse rivestite con film - ciprofloxacinum 500 mg ut ciprofloxacini hydrochloridum, cellulosum microcristallinum, maydis amylum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 4000, e 171, pro compresso obducto. - malattie infettive - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - ciprofloxacinum - compresse rivestite con film - ciprofloxacinum 250 mg ut ciprofloxacini hydrochloridum, cellulosum microcristallinum, maydis amylum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 4000, e 171, pro compresso obducto. - malattie infettive - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - ciprofloxacinum - compresse rivestite con film - ciprofloxacinum 750 mg ut ciprofloxacini hydrochloridum, cellulosum microcristallinum, maydis amylum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 4000, e 171, pro compresso obducto. - malattie infettive - synthetika

Unione Europea - italiano - EMA (European Medicines Agency)

takeda manufacturing austria ag - proteina umana c - purpura fulminans; protein c deficiency - agenti antitrombotici - ceprotin is indicated for prophylaxis and treatment of  purpura fulminans  coumarin-induced skin necrosis and venous thrombotic events in patients with severe congenital protein c deficiency.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - ciprofloxacinum - granuli e solvente per sospensione orale - praeparatio sicca: ciprofloxacinum 10 g, acidi ethacrylici et methylis methacrylatis polymerisatum, magnesii stearas, hypromellosum, polysorbatum 20, povidonum k 25, ad granulatum pro vitro. diluens: lecithinum ex soja, triglycerida media, aromatica (erdbeer; enthält alcohol benzylicus), saccharum 25.783 g aqua purificata ad solutionem pro vitro, corresp. 86 ml. suspensio reconstituta: ciprofloxacinum 500 mg, saccharum 1.3 g, in suspensione recenter reconstituta 5 ml. - malattie infettive - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - ciprofloxacinum - compresse rivestite con film - ciprofloxacinum 500 mg ciprofloxacini hydrochloridum, excipiens pro compresso haze. - malattie infettive - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - ciprofloxacinum - compresse rivestite con film - ciprofloxacinum 500 mg ciprofloxacini hydrochloridum, excipiens pro compresso haze. - malattie infettive - synthetika

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

gekofar s.r.l. - ciprofloxacina - ciprofloxacina

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - ciprofloxacinum - granuli e solvente per sospensione orale - praeparatio sicca: ciprofloxacinum 5 g, acidi ethacrylici et methylis methacrylatis polymerisatum, magnesii stearas, hypromellosum, polysorbatum 20, povidonum k 25, ad granulatum pro vitro. diluens: lecithinum ex soja, triglycerida media, aromatica (erdbeer; enthält alcohol benzylicus), saccharum 27.891 g, aqua purificata ad solutionem pro vitro, corresp. 93 ml. suspensio reconstituta: ciprofloxacinum 250 mg, saccharum 1.4 g in suspensione recenter reconstituta 5 ml. - malattie infettive - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - proteinum humanum c - polvere e solvente per soluzione iniettabile - praeparatio cryodesiccata: proteinum humanum c 500 u.i., albuminum humanum, natrii chloridum, natrii citras dihydricus, pro vitro corresp. natrium 22.5 mg. solvens: aqua ad iniectabile. - ceprotin ist zur prophylaxe und behandlung von purpura fulminans, cumarin-induzierter hautnekrose und venösen thrombotischen ereignissen bei patienten mit schwerem kongenitalem protein c-mangel indiziert. - emoderivati